Reuters logo
BRIEF-BioPharmX completes last subject visit in its phase 2B trial of BPX-01, expects to report topline results first half of May
2017年4月20日 / 下午1点48分 / 5 个月前

BRIEF-BioPharmX completes last subject visit in its phase 2B trial of BPX-01, expects to report topline results first half of May

April 20 (Reuters) - BioPharmX Corp

* BioPharmX completes last subject visit in its phase 2B trial of BPX-01, expects to report topline results first half of May 2017

* BioPharmX Corp- Expects to report topline results first half of May 2017 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below